STERLING HEIGHTS, Mich., April 18, 2016 -- IMPCO Automotive, a division of IMPCO Technologies, Inc. and Fuel Systems Solutions, Inc., has received certification by the Air Resources Board (ARB) and Environmental Protection Agency (EPA) for its bi-fuel system installed on the 2016 6.0L Chevrolet Express and GMC Savana 2500/3500 cargo and Passenger Vans.
Achieving this certification solidifies IMPCO’s leadership position within the automotive alternative fuel market and expands IMPCO Automotive’s extensive list of OEM light and medium duty platforms that operate on CNG and LPG.
“Offering a bi-fuel passenger and cargo van on the popular GM Express and Savana platforms fulfills a void in the market for working class bi-fuel CNG van solutions. Retrofits are available for fleets with existing model year 2016 inventory. This product will close the gap on a very limited list of bi-fuel solutions that can fulfil the needs of the states that require ARB certifications.” – Jeff Hall, Director of Sales
For a complete line up of IMPCO’s product offering, please visit www.impcoautomotive.com
About Fuel Systems Solutions
Fuel Systems Solutions is a leading designer, manufacturer and supplier of proven, cost-effective alternative fuel components and systems for use in transportation and industrial applications. Fuel Systems’ components and systems control the pressure and flow of gaseous alternative fuels, such as propane and natural gas, used in internal combustion engines. These components and systems feature the Company’s advanced fuel system technologies, which improve efficiency, enhance power output and reduce emissions by electronically sensing and regulating the proper proportion of fuel and air required by the internal combustion engine. In addition to the components and systems, the Company provides engineering and systems integration services to address unique customer requirements for performance, durability and configuration. Additional information is available at www.fuelsystemssolutions.com.
About IMPCO Automotive
IMPCO Automotive, a division of IMPCO Technologies, Inc., is a cost effective, designer, manufacturer, calibrator and installer of innovative bi-fuel and dedicated gaseous fuel systems (CNG/LPG), focused on the North American passenger car, and light and medium duty truck alternative fuels markets. IMPCO Automotive offers a “one-stop shop” for alternative fuels solutions for customers through their North American distributor network and their high volume, OEM conversion center in Union City, Indiana. Additional information is available at www.impcoautomotive.com
IMPCO AUTOMOTIVE CONTACT Jeff Hall, Director of Sales and Marketing [email protected] (765)-960-7719 INVESTOR CONTACT: LHA: Carolyn Capaccio / Cathy Mattison - [email protected] (415) 433-3777


7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 



